July 17, 2026European Heart Journal0 citations

Translating evidence of beta-blocker effectiveness following myocardial infarction

Key Points

Key points are not available for this paper at this time.

Abstract

This editorial refers to ‘Outcomes in the BETAMI-DANBLOCK trial compared with a Norwegian nationwide myocardial infarction population’, by A.M.D. Kristense

Ask AI

Helpful

Bookmark

View Full Paper

Cite This Study

Raveendra et al. (Fri,) studied this question.

synapsesocial.com/papers/6a5efe4a4b5cbccdc306a41e https://doi.org/https://doi.org/10.1093/eurheartj/ehag506

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Eligibility Criteria of Randomized Controlled Trials Published in High-Impact General Medical Journals2007 · 1,067 citations
2Withholding beta-blockers after myocardial infarction: reasons to be cautious2026 · 1 citations
3Transportability of two heart failure trials to a disease registry using individual patient data2023 · 5 citations
4Long-term use of carvedilol in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention2018 · 128 citations
5Outcomes in the BETAMI-DANBLOCK trial compared with a Norwegian nationwide myocardial infarction population2026 · 1 citations

Ask AI

Helpful

Bookmark

View Full Paper